Study into conolidine has led to discovery of an opioid receptor in the body identified as ACKR3/CXCR7. ACKR3 is apparently probably the most desired target for conolidine, which also disregards one other four classical opioid receptors(3). This is emerging as being a promising alternative drug. Extra importantly, it’s a https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers